Zentalis Pharmaceuticals Inc
XNAS: ZNTL
Zentalis Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart
about
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1...
Read More
1.60
-0.03
(-1.84%)
388.4K
XNAS Volume
XNAS 09 Sep, 2025 5:30 PM (EDT)
Board Meeting
The board meeting for Zentalis Pharmaceuticals Inc is scheduled for today, for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Zentalis Pharmaceuticals Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..